|
Predicting survival after surgery for pancreatic adenocarcinoma: Testing accuracy of current models. |
| |
|
No Relationships to Disclose |
| |
|
Stock and Other Ownership Interests - Wheaton Eye Clinic (I) |
| |
|
Consulting or Advisory Role - LifeOmic; Novartis; Novartis; Pointcare genomics; Strata Oncology |
Research Funding - Abbvie (Inst); Apollomics (Inst); Arcus Ventures (Inst); Elevation Oncology (Inst); Genentech (Inst); Loxo (Inst); Merck (Inst); Puma Biotechnology (Inst); Seagen (Inst); Strata Oncology (Inst) |
Patents, Royalties, Other Intellectual Property - I have a patent for a method to detect recombination events with CRISPR-mediated editing.; I have a patent for conducting expansion microscopy without specialized equipment.; I have patent for implantable/localized drug delivery device that can sample the tumor microenvironment and deliver drug. |
Travel, Accommodations, Expenses - Lifeomic |
| |
|
No Relationships to Disclose |
| |
|
Research Funding - Celgene |
| |
|
Consulting or Advisory Role - Medtronic; Precisca |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Patents, Royalties, Other Intellectual Property - University of Chicago; University of Chicago (Inst) |
| |
|
No Relationships to Disclose |